{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:39:51Z","timestamp":1790033991492,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key project of Hangzhou Agricultural and Social Development Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,5,23]]},"DOI":"10.1038\/s41388-026-03766-0","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:13:00Z","timestamp":1775265180000},"page":"1700-1713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["S100A6 promotes liver metastasis by activating FGFR3 signaling in BAP1-deficient uveal melanoma"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6833-0140","authenticated-orcid":false,"given":"Yonghao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Churun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhua","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-9370","authenticated-orcid":false,"given":"Yanyan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-6251","authenticated-orcid":false,"given":"Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-7395","authenticated-orcid":false,"given":"Xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-4031","authenticated-orcid":false,"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"3766_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev Dis Prim. 2020;6:24.","journal-title":"Nat Rev Dis Prim"},{"key":"3766_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101041","volume":"90","author":"ES Rantala","year":"2022","unstructured":"Rantala ES, Hernberg MM, Piperno-Neumann S, Grossniklaus HE, Kivela TT. Metastatic uveal melanoma: the final frontier. Prog Retin Eye Res. 2022;90:101041.","journal-title":"Prog Retin Eye Res"},{"key":"3766_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","volume":"20","author":"RD Carvajal","year":"2023","unstructured":"Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, et al. Advances in the clinical management of uveal melanoma. Nat Rev Clin Oncol. 2023;20:99\u2013115.","journal-title":"Nat Rev Clin Oncol"},{"key":"3766_CR4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410\u20133.","journal-title":"Science"},{"key":"3766_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189267","volume":"1880","author":"AM Elsayed","year":"2025","unstructured":"Elsayed AM, Kittaneh M, Cebulla CM, Abdel-Rahman MH. An overview of BAP1 biological functions and current therapeutics. Biochim Biophys Acta Rev Cancer. 2025;1880:189267.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3766_CR6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/ijms24021341","volume":"24","author":"W Lesniak","year":"2023","unstructured":"Lesniak W, Filipek A. S100A6 protein-expression and function in norm and pathology. Int J Mol Sci. 2023;24:1341.","journal-title":"Int J Mol Sci"},{"key":"3766_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00515-3","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Kang X, Kang X, Yang F. S100A6: molecular function and biomarker role. Biomark Res. 2023;11:78.","journal-title":"Biomark Res"},{"key":"3766_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216709","volume":"587","author":"T Chen","year":"2024","unstructured":"Chen T, Ruan Y, Ji L, Cai J, Tong M, Xue Y, et al. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE\/NF-kB\/VEGF-D pathway. Cancer Lett. 2024;587:216709.","journal-title":"Cancer Lett"},{"key":"3766_CR9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.str.2016.09.011","volume":"24","author":"L Yatime","year":"2016","unstructured":"Yatime L, Betzer C, Jensen RK, Mortensen S, Jensen PH, Andersen GR. The structure of the RAGE:S100A6 complex reveals a unique mode of homodimerization for S100 proteins. Structure. 2016;24:2043\u201352.","journal-title":"Structure"},{"key":"3766_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, et al. FGF\/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020;5:181.","journal-title":"Signal Transduct Target Ther"},{"key":"3766_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157399","volume":"132","author":"M Qi","year":"2022","unstructured":"Qi M, Fan S, Huang M, Pan J, Li Y, Miao Q, et al. Targeting FAPalpha-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models. J Clin Invest. 2022;132:e157399.","journal-title":"J Clin Invest"},{"key":"3766_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302613","volume":"10","author":"C Li","year":"2023","unstructured":"Li C, Chen T, Liu J, Wang Y, Zhang C, Guo L, et al. FGF19-induced inflammatory CAF promoted neutrophil extracellular trap formation in the liver metastasis of colorectal cancer. Adv Sci. 2023;10:e2302613.","journal-title":"Adv Sci"},{"key":"3766_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/pcmr.12345","volume":"28","author":"X Yu","year":"2015","unstructured":"Yu X, Ambrosini G, Roszik J, Eterovic AK, Stempke-Hale K, Seftor EA, et al. Genetic analysis of the \u2018uveal melanoma\u2019 C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line. Pigment Cell Melanoma Res. 2015;28:357\u20139.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3766_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05522-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Ding P, Wang Y, Shao C, Guo K, Yang H, et al. HDAC7\/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells. Cell Death Dis. 2023;14:38.","journal-title":"Cell Death Dis"},{"key":"3766_CR15","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.7150\/thno.33139","volume":"9","author":"J Liu","year":"2019","unstructured":"Liu J, Huang Z, Yang L, Wang X, Wang S, Li C, et al. Embryonic stem cells modulate the cancer-permissive microenvironment of human uveal melanoma. Theranostics. 2019;9:4764\u201378.","journal-title":"Theranostics"},{"key":"3766_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05590-w","volume":"14","author":"B Liu","year":"2023","unstructured":"Liu B, Yao X, Zhang C, Liu Y, Wei L, Huang Q, et al. PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation. Cell Death Dis. 2023;14:55.","journal-title":"Cell Death Dis"},{"key":"3766_CR17","first-page":"4757","volume":"63","author":"AR Hess","year":"2003","unstructured":"Hess AR, Seftor EA, Seftor RE, Hendrix MJ. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 2003;63:4757\u201362.","journal-title":"Cancer Res"},{"key":"3766_CR18","doi-asserted-by":"publisher","first-page":"9851","DOI":"10.1158\/0008-5472.CAN-05-2172","volume":"65","author":"AR Hess","year":"2005","unstructured":"Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, et al. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res. 2005;65:9851\u201360.","journal-title":"Cancer Res"},{"key":"3766_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117471","volume":"180","author":"P Yi","year":"2024","unstructured":"Yi P, Zhang R, Qin Z, Zhao X, Wu C, Yu Y, et al. Local anesthetic tetracaine hydrochloride induces pyroptosis via caspase-3\/gasdermin E in uveal melanoma. Biomed Pharmacother. 2024;180:117471.","journal-title":"Biomed Pharmacother"},{"key":"3766_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3892\/ijmm.2024.5420","volume":"54","author":"X Jiu","year":"2024","unstructured":"Jiu X, Li W, Liu Y, Liu L, Lu H. TREM2, a critical activator of pyroptosis, mediates the anti\u2011tumor effects of piceatannol in uveal melanoma cells via caspase 3\/GSDME pathway. Int J Mol Med. 2024;54:96.","journal-title":"Int J Mol Med"},{"key":"3766_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-023-01706-y","volume":"9","author":"T Yuan","year":"2024","unstructured":"Yuan T, Zeng C, Liu J, Zhao C, Ge F, Li Y, et al. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity. Signal Transduct Target Ther. 2024;9:11.","journal-title":"Signal Transduct Target Ther"},{"key":"3766_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2020.05.003","volume":"71","author":"P Bustamante","year":"2021","unstructured":"Bustamante P, Piquet L, Landreville S, Burnier JV. Uveal melanoma pathobiology: metastasis to the liver. Semin Cancer Biol. 2021;71:65\u201385.","journal-title":"Semin Cancer Biol"},{"key":"3766_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100800","volume":"75","author":"KN Smit","year":"2020","unstructured":"Smit KN, Jager MJ, de Klein A, Kili\u04ab E. Uveal melanoma: towards a molecular understanding. Prog Retin Eye Res. 2020;75:100800.","journal-title":"Prog Retin Eye Res"},{"key":"3766_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ophtha.2017.07.018","volume":"125","author":"E Szalai","year":"2018","unstructured":"Szalai E, Wells JR, Ward L, Grossniklaus HE. Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis. Ophthalmology. 2018;125:203\u20139.","journal-title":"Ophthalmology"},{"key":"3766_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cjp2.86","volume":"4","author":"N Farquhar","year":"2018","unstructured":"Farquhar N, Thornton S, Coupland SE, Coulson JM, Sacco JJ, Krishna Y, et al. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. J Pathol Clin Res. 2018;4:26\u201338.","journal-title":"J Pathol Clin Res"},{"key":"3766_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s13402-023-00908-4","volume":"47","author":"J Li","year":"2024","unstructured":"Li J, Cao D, Jiang L, Zheng Y, Shao S, Zhuang A, et al. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures. Cell Oncol. 2024;47:951\u201365.","journal-title":"Cell Oncol"},{"key":"3766_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96\u2013109.","journal-title":"Nat Rev Cancer"},{"key":"3766_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s43018-021-00199-4","volume":"2","author":"L Wang","year":"2021","unstructured":"Wang L, Birch NW, Zhao Z, Nestler CM, Kazmer A, Shilati A, et al. Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia. Nat Cancer. 2021;2:515\u201326.","journal-title":"Nat Cancer"},{"key":"3766_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"3766_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/002215549704500710","volume":"45","author":"SE Hughes","year":"1997","unstructured":"Hughes SE. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem. 1997;45:1005\u201319.","journal-title":"J Histochem Cytochem"},{"key":"3766_CR31","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1158\/0008-5472.CAN-20-3430","volume":"81","author":"A Han","year":"2021","unstructured":"Han A, Purwin TJ, Aplin AE. Roles of the BAP1 tumor suppressor in cell metabolism. Cancer Res. 2021;81:2807\u201314.","journal-title":"Cancer Res"},{"key":"3766_CR32","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1016\/j.molcel.2021.06.020","volume":"81","author":"E Conway","year":"2021","unstructured":"Conway E, Rossi F, Fernandez-Perez D, Ponzo E, Ferrari KJ, Zanotti M, et al. BAP1 enhances Polycomb repression by counteracting widespread H2AK119ub1 deposition and chromatin condensation. Mol Cell. 2021;81:3526\u201341.","journal-title":"Mol Cell"},{"key":"3766_CR33","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.molcel.2024.02.017","volume":"84","author":"J Zhao","year":"2024","unstructured":"Zhao J, Lan J, Wang M, Liu C, Fang Z, Song A, et al. H2AK119ub1 differentially fine-tunes gene expression by modulating canonical PRC1- and H1-dependent chromatin compaction. Mol Cell. 2024;84:1191\u2013205.","journal-title":"Mol Cell"},{"key":"3766_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20060195","volume":"396","author":"L Santamaria-Kisiel","year":"2006","unstructured":"Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J. 2006;396:201\u201314.","journal-title":"Biochem J"},{"key":"3766_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s43018-023-00524-z","volume":"4","author":"WY Park","year":"2023","unstructured":"Park WY, Gray JM, Holewinski RJ, Andresson T, So JY, Carmona-Rivera C, et al. Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway. Nat Cancer. 2023;4:419\u201335.","journal-title":"Nat Cancer"},{"key":"3766_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41416-022-01833-3","volume":"127","author":"F Schmid","year":"2022","unstructured":"Schmid F, Dahlmann M, Rohrich H, Kobelt D, Hoffmann J, Burock S, et al. Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker. Br J Cancer. 2022;127:675\u201385.","journal-title":"Br J Cancer"},{"key":"3766_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.696871","volume":"9","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Zhang K, Li Z, Zhang H, Fu F, Fu J, et al. High migration and invasion ability of PGCCs and their daughter cells associated with the nuclear localization of S100A10 modified by SUMOylation. Front Cell Dev Biol. 2021;9:696871.","journal-title":"Front Cell Dev Biol"},{"key":"3766_CR38","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1111\/cas.14659","volume":"111","author":"H Yanagi","year":"2020","unstructured":"Yanagi H, Watanabe T, Nishimura T, Hayashi T, Kono S, Tsuchida H, et al. Upregulation of S100A10 in metastasized breast cancer stem cells. Cancer Sci. 2020;111:4359\u201370.","journal-title":"Cancer Sci"},{"key":"3766_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaophthalmol.2013.2547","volume":"131","author":"HE Grossniklaus","year":"2013","unstructured":"Grossniklaus HE. Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture. JAMA Ophthalmol. 2013;131:462\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"3766_CR40","first-page":"345","volume":"31","author":"V Barak","year":"2011","unstructured":"Barak V, Kaiserman I, Frenkel S, Hendler K, Kalickman I, Pe\u2019er J. The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1). Anticancer Res. 2011;31:345\u20139.","journal-title":"Anticancer Res"},{"key":"3766_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-56553-3_1","volume":"161","author":"Z Kmiec","year":"2001","unstructured":"Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001;161:1\u2013151.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"3766_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann F, Tacke F. Immunology in the liver-from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13:88\u2013110.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3766_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41575-023-00821-z","volume":"20","author":"B Cogliati","year":"2023","unstructured":"Cogliati B, Yashaswini CN, Wang S, Sia D, Friedman SL. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat Rev Gastroenterol Hepatol. 2023;20:647\u201361.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3766_CR44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jare.2024.05.031","volume":"71","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang X, Gu W, Su H, Wang X, Wang X, et al. Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: mechanisms and therapeutic prospects. J Adv Res. 2025;71:399\u2013413.","journal-title":"J Adv Res"},{"key":"3766_CR45","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","volume":"79","author":"Y Mizutani","year":"2019","unstructured":"Mizutani Y, Kobayashi H, Iida T, Asai N, Masamune A, Hara A, et al. Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis. Cancer Res. 2019;79:5367\u201381.","journal-title":"Cancer Res"},{"key":"3766_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","volume":"21","author":"M Katoh","year":"2024","unstructured":"Katoh M, Loriot Y, Brandi G, Tavolari S, Wainberg ZA, Katoh M. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin Oncol. 2024;21:312\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"3766_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","volume":"17","author":"P Zhang","year":"2024","unstructured":"Zhang P, Yue L, Leng Q, Chang C, Gan C, Ye T, et al. Targeting FGFR for cancer therapy. J Hematol Oncol. 2024;17:39.","journal-title":"J Hematol Oncol"},{"key":"3766_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21:671\u201384.","journal-title":"Lancet Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03766-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T22:23:34Z","timestamp":1777847014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":48,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,5,23]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03766-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}